Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations

Ji, Xiaoyu, Jiang, Rongrong, Liu, Tao, Provencio, Mariano, Lee, Sang Chul, Zhan, Qiong, Zhou, Xinli
ISSN / E-ISSN
— / —
DOI
10.21037/tlcr-24-477 ↗
Volume · Issue · Pages
13 · 7 · —
Publisher
AME Publishing Company
Article URL
https://tlcr.amegroups.org/article/view/88409 ↗
Article details
Unverified
Publication date (each date has its type and source)
30 Jul 2024
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
Dates on record for this article
TypeDateSource
Publisher publication date30 Jul 2024 Journal websites (OAI-PMH feeds of Open Journal Systems)

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized W
Based on the recorded HEC dataset applicable to the article's publication date. Listed as W in the HEC list for 2023–24.
Journal
Translational Lung Cancer Research
Publication date used
30 Jul 2024 (Publisher publication date)
Applicable HEC period
2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
Category
W
Recognition status
Recognized (OK_RECORD_FOUND)
Source
HJRS 2023-24 page 959, row 6669
Verification status
Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.